|
| Human CD24 Protein (LTP10557) |
|
| LTP10557 |
|
| 100ug |
|
|
$822 In stock |
| CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |
| Recombinant Human CD24 Protein is expressed from E.coli with GST at the N-terminal. It contains Ser27-Gly59. |
|
| CD24 |
|
| Human |
|
| P25063 |
|
| Ser27-Gly59 |
|
| The protein has a predicted MW of 31.6 kDa same as Tris-Bis PAGE result. |
|
| Immobilized Human CD24, GST Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 17.7ng/ml determined by ELISA. See testing image for detail. |
|
| N-GST |
|
| E.coli |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
